Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |